Nektar Therapeutics (NKTR) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to -$7.2 million.
- Nektar Therapeutics' Other Gross PP&E Adjustments rose 2000.22% to -$7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.2 million, marking a year-over-year increase of 2000.22%. This contributed to the annual value of -$28.3 million for FY2024, which is 2596.29% up from last year.
- As of Q3 2025, Nektar Therapeutics' Other Gross PP&E Adjustments stood at -$7.2 million, which was up 2000.22% from -$7.6 million recorded in Q2 2025.
- Nektar Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $110.4 million for Q2 2022, and its period low was -$125.0 million during Q1 2021.
- In the last 5 years, Nektar Therapeutics' Other Gross PP&E Adjustments had a median value of -$19.2 million in 2023 and averaged -$27.3 million.
- Data for Nektar Therapeutics' Other Gross PP&E Adjustments shows a peak YoY increase of 19018.49% (in 2022) and a maximum YoY decrease of 27829.41% (in 2022) over the last 5 years.
- Quarter analysis of 5 years shows Nektar Therapeutics' Other Gross PP&E Adjustments stood at $43.8 million in 2021, then tumbled by 278.29% to -$78.1 million in 2022, then skyrocketed by 51.08% to -$38.2 million in 2023, then grew by 25.96% to -$28.3 million in 2024, then skyrocketed by 74.64% to -$7.2 million in 2025.
- Its Other Gross PP&E Adjustments was -$7.2 million in Q3 2025, compared to -$7.6 million in Q2 2025 and -$8.0 million in Q1 2025.